These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 20331542)
1. Differences in sino-atrial and atrio-ventricular function with age and sex attributable to the Scn5a+/- mutation in a murine cardiac model. Jeevaratnam K; Zhang Y; Guzadhur L; Duehmke RM; Lei M; Grace AA; Huang CL Acta Physiol (Oxf); 2010 Sep; 200(1):23-33. PubMed ID: 20331542 [TBL] [Abstract][Full Text] [Related]
2. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome. Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757 [TBL] [Abstract][Full Text] [Related]
6. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Yokokawa M; Noda T; Okamura H; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S; Shimizu W Am J Cardiol; 2007 Aug; 100(4):649-55. PubMed ID: 17697823 [TBL] [Abstract][Full Text] [Related]
7. Mutation-specific effects of lidocaine in Brugada syndrome. Clancy CE; Wehrens XH Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312 [TBL] [Abstract][Full Text] [Related]
8. Sodium channelopathies: do we really understand what's going on? Postema PG; Mosterd A; Hofman N; Alders M; Wilde AA J Cardiovasc Electrophysiol; 2011 May; 22(5):590-3. PubMed ID: 20812931 [TBL] [Abstract][Full Text] [Related]
9. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634 [TBL] [Abstract][Full Text] [Related]
10. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome. Amin AS; Boink GJ; Atrafi F; Spanjaart AM; Asghari-Roodsari A; Molenaar RJ; Ruijter JM; Wilde AA; Tan HL Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195 [TBL] [Abstract][Full Text] [Related]
11. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts. Herbert E; Chahine M Can J Physiol Pharmacol; 2006; 84(8-9):795-802. PubMed ID: 17111025 [TBL] [Abstract][Full Text] [Related]
13. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160 [TBL] [Abstract][Full Text] [Related]
14. Exercise-induced ECG changes in Brugada syndrome. Amin AS; de Groot EA; Ruijter JM; Wilde AA; Tan HL Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):531-9. PubMed ID: 19843921 [TBL] [Abstract][Full Text] [Related]
15. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707 [TBL] [Abstract][Full Text] [Related]